🇸🇬 SG S68.SI

Singapore Exchange — Regulated Monopoly & Derivatives Growth Re-Rating

🏢 Singapore Exchange Ltd ✍️ AiAlphaLens Research 📅 March 17, 2026

Research Summary

SGX holds exclusive listing and trading rights for Singapore equities, derivatives, and fixed income — an unassailable regulatory moat. Derivatives revenue growing 15%+ annually, now 55%+ of total revenue. BUY | PT S$21.50 (+21% upside from S$17.72).

Read the Full Research Report

Access the complete analysis, financial model, price target breakdown, and risk factors.

Read Full Report →

2 free reads per day · No credit card required